老人用医薬品の世界市場 2023-2027

老人用医薬品市場は2022-2027年に448億5,000万米ドル、予測期間中のCAGRは6.81%で成長すると予測されています。

当レポートでは、老人用医薬品市場の全体的な分析、市場規模・予測、動向、市場促進要因・促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、高齢者人口の増加、個別化医療への需要、政府やNGOによる高齢者支援の増加によって牽引されています。

本調査では、今後数年間の老人用医薬品市場の成長を牽引する主な要因として、治療アプローチの増加を挙げています。また、戦略的提携や買収、高齢者の健康状態を遠隔監視する積極的な役割分担も、市場の大きな需要につながると思われます。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2022
• 市場の見通し 2022-2027

第4章 市場規模実績

• 老人用医薬品の世界市場 2017-2021
• 流通チャネルセグメント分析 2017-2021
• タイプセグメント分析 2017-2021
• 地域別セグメント分析 2017-2021
• 国別セグメント分析 2017-2021

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：流通チャネル別

• 市場セグメント
• 比較：流通チャネル別
• 病院薬局：市場規模と予測 2022-2027
• 小売薬局：市場規模と予測 2022-2027
• オンライン薬局：市場規模と予測 2022-2027
• 市場機会：流通チャネル別

第7章 市場セグメンテーション：タイプ別

• 市場セグメント
• 比較：タイプ別
• 鎮痛剤：市場規模と予測 2022-2027
• 抗糖尿病薬：市場規模と予測 2022-2027
• 降圧剤：市場規模と予測 2022-2027
• スタチン：市場規模と予測 2022-2027
• その他：市場規模と予測 2022-2027
• 市場機会：タイプ別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2022-2027
• 欧州：市場規模と予測 2022-2027
• アジア：市場規模と予測 2022-2027
• 世界のその他の地域：市場規模と予測 2022-2027
• 米国：市場規模と予測 2022-2027
• カナダ：市場規模と予測 2022-2027
• ドイツ：市場規模と予測 2022-2027
• 中国：市場規模と予測 2022-2027
• インド：市場規模と予測 2022-2027
• 地域情勢別市場機会

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• Abbott Laboratories
• AbbVie Inc.
• AstraZeneca PLC
• Boehringer Ingelheim International GmbH
• Bristol Myers Squibb Co.
• Dr Reddys Laboratories Ltd.
• Eli Lilly and Co.
• Endo International Plc
• GlaxoSmithKline Plc
• Merck and Co. Inc.
• Novartis AG
• Otsuka Holdings Co. Ltd.
• Pfizer Inc.
• Sanofi
• Teva Pharmaceutical Industries Ltd.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibits6: Executive Summary - Chart on Market Segmentation by Type
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on global geriatric medicines market 2017 - 2021 ($ billion)
• Exhibits19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ billion)
• Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on Distribution Channel - Market share 2022-2027 (%)
• Exhibits31: Data Table on Distribution Channel - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by Distribution Channel
• Exhibits33: Data Table on Comparison by Distribution Channel
• Exhibits34: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibits35: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibits36: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibits39: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibits40: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibits42: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibits43: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibits44: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibits45: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibits46: Market opportunity by Distribution Channel ($ billion)
• Exhibits47: Data Table on Market opportunity by Distribution Channel ($ billion)
• Exhibits48: Chart on Type - Market share 2022-2027 (%)
• Exhibits49: Data Table on Type - Market share 2022-2027 (%)
• Exhibits50: Chart on Comparison by Type
• Exhibits51: Data Table on Comparison by Type
• Exhibits52: Chart on Analgesics - Market size and forecast 2022-2027 ($ billion)
• Exhibits53: Data Table on Analgesics - Market size and forecast 2022-2027 ($ billion)
• Exhibits54: Chart on Analgesics - Year-over-year growth 2022-2027 (%)
• Exhibits55: Data Table on Analgesics - Year-over-year growth 2022-2027 (%)
• Exhibits56: Chart on Antidiabetics - Market size and forecast 2022-2027 ($ billion)
• Exhibits57: Data Table on Antidiabetics - Market size and forecast 2022-2027 ($ billion)
• Exhibits58: Chart on Antidiabetics - Year-over-year growth 2022-2027 (%)
• Exhibits59: Data Table on Antidiabetics - Year-over-year growth 2022-2027 (%)
• Exhibits60: Chart on Antihypertensives - Market size and forecast 2022-2027 ($ billion)
• Exhibits61: Data Table on Antihypertensives - Market size and forecast 2022-2027 ($ billion)
• Exhibits62: Chart on Antihypertensives - Year-over-year growth 2022-2027 (%)
• Exhibits63: Data Table on Antihypertensives - Year-over-year growth 2022-2027 (%)
• Exhibits64: Chart on Statins - Market size and forecast 2022-2027 ($ billion)
• Exhibits65: Data Table on Statins - Market size and forecast 2022-2027 ($ billion)
• Exhibits66: Chart on Statins - Year-over-year growth 2022-2027 (%)
• Exhibits67: Data Table on Statins - Year-over-year growth 2022-2027 (%)
• Exhibits68: Chart on Others - Market size and forecast 2022-2027 ($ billion)
• Exhibits69: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
• Exhibits70: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibits71: Data Table on Others - Year-over-year growth 2022-2027 (%)
• Exhibits72: Market opportunity by Type ($ billion)
• Exhibits73: Data Table on Market opportunity by Type ($ billion)
• Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits75: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits76: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits77: Chart on Geographic comparison
• Exhibits78: Data Table on Geographic comparison
• Exhibits79: Chart on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibits80: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibits81: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits82: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits83: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibits84: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibits85: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits87: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibits88: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibits89: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits90: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibits92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibits93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits95: Chart on US - Market size and forecast 2022-2027 ($ billion)
• Exhibits96: Data Table on US - Market size and forecast 2022-2027 ($ billion)
• Exhibits97: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits98: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits99: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
• Exhibits100: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
• Exhibits101: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits103: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibits104: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibits105: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits106: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits107: Chart on China - Market size and forecast 2022-2027 ($ billion)
• Exhibits108: Data Table on China - Market size and forecast 2022-2027 ($ billion)
• Exhibits109: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibits110: Data Table on China - Year-over-year growth 2022-2027 (%)
• Exhibits111: Chart on India - Market size and forecast 2022-2027 ($ billion)
• Exhibits112: Data Table on India - Market size and forecast 2022-2027 ($ billion)
• Exhibits113: Chart on India - Year-over-year growth 2022-2027 (%)
• Exhibits114: Data Table on India - Year-over-year growth 2022-2027 (%)
• Exhibits115: Market opportunity By Geographical Landscape ($ billion)
• Exhibits116: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• Exhibits117: Impact of drivers and challenges in 2022 and 2027
• Exhibits118: Overview on Criticality of inputs and Factors of differentiation
• Exhibits119: Overview on factors of disruption
• Exhibits120: Impact of key risks on business
• Exhibits121: Vendors covered
• Exhibits122: Matrix on vendor position and classification
• Exhibits123: Abbott Laboratories - Overview
• Exhibits124: Abbott Laboratories - Business segments
• Exhibits125: Abbott Laboratories - Key offerings
• Exhibits126: Abbott Laboratories - Segment focus
• Exhibits127: AbbVie Inc. - Overview
• Exhibits128: AbbVie Inc. - Product / Service
• Exhibits129: AbbVie Inc. - Key news
• Exhibits130: AbbVie Inc. - Key offerings
• Exhibits131: AstraZeneca PLC - Overview
• Exhibits132: AstraZeneca PLC - Product / Service
• Exhibits133: AstraZeneca PLC - Key news
• Exhibits134: AstraZeneca PLC - Key offerings
• Exhibits135: Boehringer Ingelheim International GmbH - Overview
• Exhibits136: Boehringer Ingelheim International GmbH - Business segments
• Exhibits137: Boehringer Ingelheim International GmbH - Key news
• Exhibits138: Boehringer Ingelheim International GmbH - Key offerings
• Exhibits139: Boehringer Ingelheim International GmbH - Segment focus
• Exhibits140: Bristol Myers Squibb Co. - Overview
• Exhibits141: Bristol Myers Squibb Co. - Product / Service
• Exhibits142: Bristol Myers Squibb Co. - Key news
• Exhibits143: Bristol Myers Squibb Co. - Key offerings
• Exhibits144: Dr Reddys Laboratories Ltd. - Overview
• Exhibits145: Dr Reddys Laboratories Ltd. - Business segments
• Exhibits146: Dr Reddys Laboratories Ltd. - Key offerings
• Exhibits147: Dr Reddys Laboratories Ltd. - Segment focus
• Exhibits148: Eli Lilly and Co. - Overview
• Exhibits149: Eli Lilly and Co. - Product / Service
• Exhibits150: Eli Lilly and Co. - Key news
• Exhibits151: Eli Lilly and Co. - Key offerings
• Exhibits152: Endo International Plc - Overview
• Exhibits153: Endo International Plc - Business segments
• Exhibits154: Endo International Plc - Key news
• Exhibits155: Endo International Plc - Key offerings
• Exhibits156: Endo International Plc - Segment focus
• Exhibits157: GlaxoSmithKline Plc - Overview
• Exhibits158: GlaxoSmithKline Plc - Business segments
• Exhibits159: GlaxoSmithKline Plc - Key news
• Exhibits160: GlaxoSmithKline Plc - Key offerings
• Exhibits161: GlaxoSmithKline Plc - Segment focus
• Exhibits162: Merck and Co. Inc. - Overview
• Exhibits163: Merck and Co. Inc. - Business segments
• Exhibits164: Merck and Co. Inc. - Key news
• Exhibits165: Merck and Co. Inc. - Key offerings
• Exhibits166: Merck and Co. Inc. - Segment focus
• Exhibits167: Novartis AG - Overview
• Exhibits168: Novartis AG - Business segments
• Exhibits169: Novartis AG - Key offerings
• Exhibits170: Novartis AG - Segment focus
• Exhibits171: Otsuka Holdings Co. Ltd. - Overview
• Exhibits172: Otsuka Holdings Co. Ltd. - Business segments
• Exhibits173: Otsuka Holdings Co. Ltd. - Key offerings
• Exhibits174: Otsuka Holdings Co. Ltd. - Segment focus
• Exhibits175: Pfizer Inc. - Overview
• Exhibits176: Pfizer Inc. - Product / Service
• Exhibits177: Pfizer Inc. - Key news
• Exhibits178: Pfizer Inc. - Key offerings
• Exhibits179: Sanofi - Overview
• Exhibits180: Sanofi - Business segments
• Exhibits181: Sanofi - Key news
• Exhibits182: Sanofi - Key offerings
• Exhibits183: Sanofi - Segment focus
• Exhibits184: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibits185: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibits186: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibits187: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibits188: Teva Pharmaceutical Industries Ltd. - Segment focus
• Exhibits189: Inclusions checklist
• Exhibits190: Exclusions checklist
• Exhibits191: Currency conversion rates for US$
• Exhibits192: Research methodology
• Exhibits193: Validation techniques employed for market sizing
• Exhibits194: Information sources
• Exhibits195: List of abbreviations

The geriatric medicines market is forecasted to grow by USD 44.85 bn during 2022-2027, accelerating at a CAGR of 6.81% during the forecast period. The report on the geriatric medicines market provides a holistic analysis, market size, and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by a growing geriatric population, demand for personalized medicine, and an increase in government and NGO supports for the elderly.

Technavio's geriatric medicines market is segmented as below:

By Distribution Channel

• Hospital pharmacies
• Retail pharmacies
• Online pharmacies

By Type

• Analgesics
• Antidiabetics
• Antihypertensives
• Statins
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the rise in therapeutic approaches as one of the prime reasons driving the geriatric medicines market growth during the next few years. Also, strategic partnerships and acquisitions and active role-play of senior citizens in monitoring their health remotely will lead to sizable demand in the market.

The report on the geriatric medicines market covers the following areas:

• Geriatric medicines market sizing
• Geriatric medicines market forecast
• Geriatric medicines market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading geriatric medicines market vendors that include Abbott Laboratories, AbbVie Inc., AstraZeneca PLC, Aurobindo Pharma Ltd., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Cipla Ltd., Dr Reddys Laboratories Ltd., Eli Lilly and Co., Endo International Plc, GlaxoSmithKline Plc, Lupin Ltd., Merck and Co. Inc., Novartis AG, Otsuka Holdings Co. Ltd., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., and Sanofi. Also, the geriatric medicines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global geriatric medicines market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on global geriatric medicines market 2017 - 2021 ($ billion)
• 4.2 Distribution Channel Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ billion)
• 4.3 Type Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Distribution Channel

• 6.1 Market segments
• Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
• 6.2 Comparison by Distribution Channel
• Exhibit 32: Chart on Comparison by Distribution Channel
• Exhibit 33: Data Table on Comparison by Distribution Channel
• 6.3 Hospital pharmacies - Market size and forecast 2022-2027
• Exhibit 34: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibit 35: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibit 36: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
• 6.4 Retail pharmacies - Market size and forecast 2022-2027
• Exhibit 38: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibit 39: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibit 40: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
• 6.5 Online pharmacies - Market size and forecast 2022-2027
• Exhibit 42: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibit 43: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibit 44: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
• 6.6 Market opportunity by Distribution Channel
• Exhibit 46: Market opportunity by Distribution Channel ($ billion)
• Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ billion)

7 Market Segmentation by Type

• 7.1 Market segments
• Exhibit 48: Chart on Type - Market share 2022-2027 (%)
• Exhibit 49: Data Table on Type - Market share 2022-2027 (%)
• 7.2 Comparison by Type
• Exhibit 50: Chart on Comparison by Type
• Exhibit 51: Data Table on Comparison by Type
• 7.3 Analgesics - Market size and forecast 2022-2027
• Exhibit 52: Chart on Analgesics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 53: Data Table on Analgesics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 54: Chart on Analgesics - Year-over-year growth 2022-2027 (%)
• Exhibit 55: Data Table on Analgesics - Year-over-year growth 2022-2027 (%)
• 7.4 Antidiabetics - Market size and forecast 2022-2027
• Exhibit 56: Chart on Antidiabetics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 57: Data Table on Antidiabetics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 58: Chart on Antidiabetics - Year-over-year growth 2022-2027 (%)
• Exhibit 59: Data Table on Antidiabetics - Year-over-year growth 2022-2027 (%)
• 7.5 Antihypertensives - Market size and forecast 2022-2027
• Exhibit 60: Chart on Antihypertensives - Market size and forecast 2022-2027 ($ billion)
• Exhibit 61: Data Table on Antihypertensives - Market size and forecast 2022-2027 ($ billion)
• Exhibit 62: Chart on Antihypertensives - Year-over-year growth 2022-2027 (%)
• Exhibit 63: Data Table on Antihypertensives - Year-over-year growth 2022-2027 (%)
• 7.6 Statins - Market size and forecast 2022-2027
• Exhibit 64: Chart on Statins - Market size and forecast 2022-2027 ($ billion)
• Exhibit 65: Data Table on Statins - Market size and forecast 2022-2027 ($ billion)
• Exhibit 66: Chart on Statins - Year-over-year growth 2022-2027 (%)
• Exhibit 67: Data Table on Statins - Year-over-year growth 2022-2027 (%)
• 7.7 Others - Market size and forecast 2022-2027
• Exhibit 68: Chart on Others - Market size and forecast 2022-2027 ($ billion)
• Exhibit 69: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
• Exhibit 70: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 71: Data Table on Others - Year-over-year growth 2022-2027 (%)
• 7.8 Market opportunity by Type
• Exhibit 72: Market opportunity by Type ($ billion)
• Exhibit 73: Data Table on Market opportunity by Type ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 75: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibit 76: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 77: Chart on Geographic comparison
• Exhibit 78: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 79: Chart on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibit 80: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibit 81: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 83: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibit 84: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibit 85: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 87: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibit 88: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibit 89: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 95: Chart on US - Market size and forecast 2022-2027 ($ billion)
• Exhibit 96: Data Table on US - Market size and forecast 2022-2027 ($ billion)
• Exhibit 97: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 Canada - Market size and forecast 2022-2027
• Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
• Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
• Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• 9.9 Germany - Market size and forecast 2022-2027
• Exhibit 103: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibit 104: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibit 105: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 106: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.10 China - Market size and forecast 2022-2027
• Exhibit 107: Chart on China - Market size and forecast 2022-2027 ($ billion)
• Exhibit 108: Data Table on China - Market size and forecast 2022-2027 ($ billion)
• Exhibit 109: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 110: Data Table on China - Year-over-year growth 2022-2027 (%)
• 9.11 India - Market size and forecast 2022-2027
• Exhibit 111: Chart on India - Market size and forecast 2022-2027 ($ billion)
• Exhibit 112: Data Table on India - Market size and forecast 2022-2027 ($ billion)
• Exhibit 113: Chart on India - Year-over-year growth 2022-2027 (%)
• Exhibit 114: Data Table on India - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 115: Market opportunity By Geographical Landscape ($ billion)
• Exhibit 116: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 117: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 119: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 120: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 121: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 122: Matrix on vendor position and classification
• 12.3 Abbott Laboratories
• Exhibit 123: Abbott Laboratories - Overview
• Exhibit 124: Abbott Laboratories - Business segments
• Exhibit 125: Abbott Laboratories - Key offerings
• Exhibit 126: Abbott Laboratories - Segment focus
• 12.4 AbbVie Inc.
• Exhibit 127: AbbVie Inc. - Overview
• Exhibit 128: AbbVie Inc. - Product / Service
• Exhibit 129: AbbVie Inc. - Key news
• Exhibit 130: AbbVie Inc. - Key offerings
• 12.5 AstraZeneca PLC
• Exhibit 131: AstraZeneca PLC - Overview
• Exhibit 132: AstraZeneca PLC - Product / Service
• Exhibit 133: AstraZeneca PLC - Key news
• Exhibit 134: AstraZeneca PLC - Key offerings
• 12.6 Boehringer Ingelheim International GmbH
• Exhibit 135: Boehringer Ingelheim International GmbH - Overview
• Exhibit 136: Boehringer Ingelheim International GmbH - Business segments
• Exhibit 137: Boehringer Ingelheim International GmbH - Key news
• Exhibit 138: Boehringer Ingelheim International GmbH - Key offerings
• Exhibit 139: Boehringer Ingelheim International GmbH - Segment focus
• 12.7 Bristol Myers Squibb Co.
• Exhibit 140: Bristol Myers Squibb Co. - Overview
• Exhibit 141: Bristol Myers Squibb Co. - Product / Service
• Exhibit 142: Bristol Myers Squibb Co. - Key news
• Exhibit 143: Bristol Myers Squibb Co. - Key offerings
• 12.8 Dr Reddys Laboratories Ltd.
• Exhibit 144: Dr Reddys Laboratories Ltd. - Overview
• Exhibit 145: Dr Reddys Laboratories Ltd. - Business segments
• Exhibit 146: Dr Reddys Laboratories Ltd. - Key offerings
• Exhibit 147: Dr Reddys Laboratories Ltd. - Segment focus
• 12.9 Eli Lilly and Co.
• Exhibit 148: Eli Lilly and Co. - Overview
• Exhibit 149: Eli Lilly and Co. - Product / Service
• Exhibit 150: Eli Lilly and Co. - Key news
• Exhibit 151: Eli Lilly and Co. - Key offerings
• 12.10 Endo International Plc
• Exhibit 152: Endo International Plc - Overview
• Exhibit 153: Endo International Plc - Business segments
• Exhibit 154: Endo International Plc - Key news
• Exhibit 155: Endo International Plc - Key offerings
• Exhibit 156: Endo International Plc - Segment focus
• 12.11 GlaxoSmithKline Plc
• Exhibit 157: GlaxoSmithKline Plc - Overview
• Exhibit 158: GlaxoSmithKline Plc - Business segments
• Exhibit 159: GlaxoSmithKline Plc - Key news
• Exhibit 160: GlaxoSmithKline Plc - Key offerings
• Exhibit 161: GlaxoSmithKline Plc - Segment focus
• 12.12 Merck and Co. Inc.
• Exhibit 162: Merck and Co. Inc. - Overview
• Exhibit 163: Merck and Co. Inc. - Business segments
• Exhibit 164: Merck and Co. Inc. - Key news
• Exhibit 165: Merck and Co. Inc. - Key offerings
• Exhibit 166: Merck and Co. Inc. - Segment focus
• 12.13 Novartis AG
• Exhibit 167: Novartis AG - Overview
• Exhibit 168: Novartis AG - Business segments
• Exhibit 169: Novartis AG - Key offerings
• Exhibit 170: Novartis AG - Segment focus
• 12.14 Otsuka Holdings Co. Ltd.
• Exhibit 171: Otsuka Holdings Co. Ltd. - Overview
• Exhibit 172: Otsuka Holdings Co. Ltd. - Business segments
• Exhibit 173: Otsuka Holdings Co. Ltd. - Key offerings
• Exhibit 174: Otsuka Holdings Co. Ltd. - Segment focus
• 12.15 Pfizer Inc.
• Exhibit 175: Pfizer Inc. - Overview
• Exhibit 176: Pfizer Inc. - Product / Service
• Exhibit 177: Pfizer Inc. - Key news
• Exhibit 178: Pfizer Inc. - Key offerings
• 12.16 Sanofi
• Exhibit 179: Sanofi - Overview
• Exhibit 180: Sanofi - Business segments
• Exhibit 181: Sanofi - Key news
• Exhibit 182: Sanofi - Key offerings
• Exhibit 183: Sanofi - Segment focus
• 12.17 Teva Pharmaceutical Industries Ltd.
• Exhibit 184: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 185: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 186: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 187: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 188: Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 189: Inclusions checklist
• Exhibit 190: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 191: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 192: Research methodology
• Exhibit 193: Validation techniques employed for market sizing
• Exhibit 194: Information sources
• 13.5 List of abbreviations
• Exhibit 195: List of abbreviations